Form 4 for KWR QUAKER CHEMICAL CORP
Accepted 2021-08-12 00:00:00 ET · period of report 2021-08-10 · accession 0001209191-21-051104 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-08-12 | 2021-08-10 | KWR | Laininger Dieter | SVP, Managing Dir - APAC | M - OptEx | $147.01 | +2,378 | 6,659 | +56% | +$349.6K |
| DM | 2021-08-12 | 2021-08-10 | KWR | Laininger Dieter | SVP, Managing Dir - APAC | S - Sale+OE | $255.05 | -2,811 | 5,303 | -35% | -$716.9K |
| DM | 2021-08-12 | 2021-08-10 | KWR | Laininger Dieter | SVP, Managing Dir - APAC | M - OptEx | $0.00 | -2,378 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-10 | M | A | 613 | $151.75 | 6,349 | D | — | — | (F1) Includes 1 share acquired in Company's Dividend Reinvestment Plan on April 30, 2021. |
| 2 | Common | Common Stock | 2021-08-10 | S | D | 613 | $255.05 | 5,736 | D | — | — | |
| 3 | Common | Common Stock | 2021-08-10 | M | A | 842 | $154.92 | 6,578 | D | — | — | |
| 4 | Common | Common Stock | 2021-08-10 | S | D | 842 | $255.05 | 5,736 | D | — | — | |
| 5 | Common | Common Stock | 2021-08-10 | M | A | 923 | $136.64 | 6,659 | D | — | — | |
| 6 | Common | Common Stock | 2021-08-10 | S | D | 923 | $255.05 | 5,736 | D | — | — | |
| 7 | Common | Common Stock | 2021-08-10 | S | D | 433 | $255.05 | 5,303 | D | — | — | |
| 8 | Derivative | Employee Stock Option (right to buy) | 2021-08-10 | M | D | 923 | $0.00 | 1,844 | D | $136.64 · — to 2027-03-30 | 923 Common Stock | (F4) The options for this grant vest in three annual installments: 923 shares on March 30, 2021; 922 shares on March 30, 2022; and 922 shares on March 30, 2023. |
| 9 | Derivative | Employee Stock Option (right to buy) | 2021-08-10 | M | D | 842 | $0.00 | 842 | D | $154.92 · — to 2026-02-25 | 842 Common Stock | (F3) The options for this grant vest in three annual installments: 842 shares on February 25, 2020; 842 shares on February 25, 2021; and 842 shares on February 25, 2022. |
| 10 | Derivative | Employee Stock Option (right to buy) | 2021-08-10 | M | D | 613 | $0.00 | 0 | D | $151.75 · — to 2025-02-26 | 613 Common Stock | (F2) The options for this grant vested in three annual installments: 614 shares on February 26, 2019; 614 shares on February 26, 2020; and 613 shares on February 26, 2021. |